Short Versus Standard Dental Implants: Clinical and Biomarker Outcomes

Sponsor
Inonu University
Study ID
NCT07828067
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Study Details

This study compares two types of dental implants, short implants (6 millimeters or less in length) and standard implants (longer than 8 millimeters), to evaluate their effect on the health of the gum and bone tissue surrounding the implant. Approximately 40 patients receiving a total of 80 dental implants will be followed. Researchers will assess clinical signs of gum health around the implants, measure specific protein levels (biomarkers) in the fluid surrounding the implants associated with gum disease. The goal of this study is to determine whether implant length affects the risk of inflammation or infection around dental implants, which may help guide treatment decisions in the future.

Key Dates

First listed
Sep 18, 2026
Start date
Sep 20, 2026
Status verified
Sep 2026
Primary completion
Dec 30, 2026
Completion
Dec 30, 2026

Study Design

Enrollment
40 participants (estimated)

Arms

  • Arm: Short implant group
    Patients receiving dental implants with a length of 6 mm or less. Peri-implant crevicular fluid (PICF) samples will be collected to assess RANKL, OPG, and cathepsin-K levels, along with clinical peri-implant tissue health parameters
  • Arm: Standard Implant Group
    Patients receiving dental implants with a length greater than 8 mm. Peri-implant crevicular fluid (PICF) samples will be collected to assess RANKL, OPG, and cathepsin-K levels, along with clinical peri-implant tissue health parameters.

Primary Outcome Measure

Change in Peri-Implant Crevicular Fluid RANKL Level [ Time Frame: Baseline; 1 and 3 months after non-surgical peri-implant therapy in participants who develop peri-implant mucositis. ]

Central Contacts

Related Studies